The Supreme Court Just Clarified How Section 2 Should Work — Software Patents Should Be Next

Andrew Currier explores how the Supreme Court of Canada's Pharmascience decision could influence the future of software patent eligibility in Canada.

READ MORE →

Stay informed. Subscribe to PCK IP’s insights for our latest commentary and updates.

Contact Us